Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Has FDA moved the goalposts?
View:
Post by Yajne on Mar 29, 2023 9:34pm

Has FDA moved the goalposts?

...can they even do that after a trial is underway and so far advanced? If so, do some folks still not take seriously the broad reach of big Pharma? If so, you are ostriches, go bury your head back in the sand!

Let's hope that somebody within FDA actually cares for the patient, rather than their own "off the record compensation". If TLT's Ph2 results don't speak for themselves and are somehow derailed by some sort of 'new rules' that didn't exist when the trial started, then I've kinda lost faith in mankind, or at least those in powerful positions. C'mon FDA, do the right thing here, many peoples lives depend on it!
Comment by ScienceFirst on Mar 29, 2023 10:07pm
No plot theories here. Thus changes nothing to the Ph. 2 trial.  Nothing.
Comment by ScienceFirst on Mar 29, 2023 10:09pm
No plot theories here. This changes nothing to the Ph. 2 trial.  Nothing.
Comment by Yajne on Mar 29, 2023 10:49pm
Okay smart guy. And you know that nothing changes to Ph2 trial because you've discussed it with the FDA, or is it just becuase you're such a smart guy? FYI you're now on the record for saying what you just posted. 
Comment by ScienceFirst on Mar 30, 2023 7:04am
Yajne... Always into plot theories? Weren't you the one that turned into ridicule COVID-19 by stating it was nothing more than a flu and that the government was wasting taxpayers money for nothing on this but that you suddenly requested that the same government should step up its investment in the COVID-19 R&D only once you son ended up catching it and spent 2 days at the hospital in ...more  
Comment by StevenBirch on Mar 30, 2023 8:40am
I'm not into conspiracy theories, the FDA grants approvals every day. Like all large organizations, government or otherwise, there is always a financial incentive to act in a certain way. However I think you have to have a persecution complex to think that TLT will be singled out as a company that the FDA has to 'stop' from succeeding.  Remember, they are not ending the gravy ...more  
Comment by Lesalpes29 on Mar 30, 2023 9:03am
Good post again Steven. It's easy to turn negatively every move or possible move by the FDA. The results so far are good enough for BTD shortly followed by the AA with more results to come. I keep my focus on this and wait for good NR to add some shares! GL
Comment by StevenBirch on Mar 30, 2023 10:26am
Thanks Lesalpes and I would add, without any knowledge, it looks like PP activity and that's not the end of the world. The bid at $0.26 is growing so that doesn't look like something negative is going on.
Comment by Rumpl3StiltSkin on Mar 29, 2023 11:22pm
I think if the drug/compound shows obvious efficacy in the lab during preclinical phase then Single arm will be pursued. Just IMO. I think the FDA is trying to stop FT and BTD to the degree that they are. I think very few actually have what it takes to make it to AA or final approval.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250